![Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? | npj Parkinson's Disease Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-017-0030-4/MediaObjects/41531_2017_30_Fig1_HTML.jpg)
Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? | npj Parkinson's Disease
![Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective](https://s3-eu-west-1.amazonaws.com/ppreviews-tf-45897as9a7sa86/8653219/thumb.png)
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective: Expert Review of Neurotherapeutics: Vol 17, No 7
![Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects - Clinical Therapeutics Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8cfb811d-a025-4005-aa42-ed454958b71f/gr1.jpg)
Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects - Clinical Therapeutics
![Rotigotine: Unexpected Polymorphism with Predictable Overall Monotropic Behavior - Journal of Pharmaceutical Sciences Rotigotine: Unexpected Polymorphism with Predictable Overall Monotropic Behavior - Journal of Pharmaceutical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2102225083/2080209709/gr1.jpg)
Rotigotine: Unexpected Polymorphism with Predictable Overall Monotropic Behavior - Journal of Pharmaceutical Sciences
![Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpjparkd.2016.23/MediaObjects/41531_2016_Article_BFnpjparkd201623_Fig1_HTML.jpg)
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
![Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/922546/f/1.png)